Aptivus Side Effects Lawsuit
Aptivus, available as Tapranavir Capsules and Tapranavir Oral Solution, is used for the combination antiretroviral treatment of HIV-1 infected patients who are infected with HIV-1 strains resistant to more than one protease inhibitor and who have tried multiple treatments.
Aptivus belongs to the class of 4-hydroxy-5,6-dihydro-2-pyrone sulfonamides and is a protease inhibitor of HIV-1 . The drug is soft gelatin capsules containing 250mg tipranavirfor oral administration. The capsules contain the major inactive ingredients propylene glycol, dehydrated alcohol, polyoxyl 35 castor oil, mono or diglycerides of caprylic or capric acid and gelatin.